PARIS, Oct. 16 /PRNewswire/ -- Galderma Pharma SA is proud to announce that President and CEO Humberto C. Antunes has served as Cartier Women's Initiative Awards Jury President for North America. Jury members for the prestigious business plan competition are chosen because of their achievements in the business, non-profit and academic fields, as well as their interest in women's issues.
The awards, an annual distinction supporting innovative woman-led business projects, were created by Cartier and the Women's Forum for the Economy and Society. The program honors five innovative business projects from women, one per continent, and awards each with a $20,000 (US) grant and coaching support for one year. The 2007 Award ceremony was held on October 11, 2007, at the Women's Forum in Deauville, France.
"I want to express my deepest admiration for Cartier's initiative and the special support of Cartier's CEO for North America, Frederic de Narp. I am honored to have been chosen to lead the North American panel of jurists," said Antunes. Galderma is one of the world's largest dermatology pharmaceutical companies, has a presence in 65 countries, has one of the largest research facilities dedicated to dermatology and provides innovative therapeutic skincare solutions to meet the needs of dermatology patients and physicians. Antunes is an active member in many foundations and associations such as the Women's Dermatologic Society and the American Skin Association.
"Start-up initiatives by women are vital and pave the way for future generations of women by passing on examples of courage, passion and perseverance," said Antunes.
"Although the number of female entrepreneurs has increased in recent years, women in business still face specific obstacles." Antunes said. "This program is valuable because it addresses those obstacles by offering the financial backing, quality coaching services and networking that can help women succeed."
"Jury member
'/>"/>
| SOURCE Galderma Laboratories Copyright©2007 PR Newswire. All rights reserved |